Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Hypnosis and self-hypnosis, administered and taught by nurses, for the reduction of chronic pain: a controlled clinical trial
ISRCTN ISRCTN32129167
ClinicalTrials.gov identifier
Public title Hypnosis and self-hypnosis, administered and taught by nurses, for the reduction of chronic pain: a controlled clinical trial
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Hypnosis and auto-hypnosis do not reduce pain in patients with chronic pain
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Switzerland
Disease/condition/study domain Various conditions engendering chronic pain
Participants - inclusion criteria 1. To be referred (including occasional self-referral) for the management of chronic pain
2. To live within manageable distances from the hospital
3. To be aged 18 or above
4. To understand and speak French adequately
5. To be able to see, hear and communicate (i.e. no alteration of consciousness)
6. To have no diagnosis of mental illness (e.g. psychosis)
7. To give informed consent
Participants - exclusion criteria Patients were excluded from the study whenever they wished and/or when no conventional treatment could be proposed.
Anticipated start date 01/05/1993
Anticipated end date 31/12/1994
Status of trial Completed
Patient information material
Target number of participants 2 x 65 = 130
Interventions Hypnosis and auto-hypnosis administered and taught by trained nurses
Primary outcome measure(s) Level of pain (VAS)
Secondary outcome measure(s) 1. Physical activity (tridimensional accelerometer)
2. Health related quality of life (SF-36)
Sources of funding Swiss National Science Foundation (Switzerland) (SNF 4034-35883)
Trial website
Publications 1994 protocol in http://www.ncbi.nlm.nih.gov/pubmed/8073244
Contact name Dr  Bernard  Burnand
  Address IUMSP
Bugnon 17
  City/town Lausanne
  Zip/Postcode CH-1010
  Country Switzerland
Sponsor Hospital of Morges (Switzerland)
  Address
  City/town Morges
  Zip/Postcode CH-1110
  Country Switzerland
Date applied 06/09/2005
Last edited 10/09/2009
Date ISRCTN assigned 04/10/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central